The Complete Guide to Bioidentical Hormones and Skin Health

The relationship between hormones and skin health is complex and bidirectional. This guide examines the evidence for bioidentical hormones, their effects on skin quality, and the considerations for patients interested in hormonally-influenced aesthetic outcomes.

Reviewed by the Axiom Aesthetics Clinical Team | Last updated: February 2026

Hormones and Skin: The Fundamental Connection

Skin is the body’s largest hormone-responsive organ, containing receptors for oestrogen, progesterone, testosterone, cortisol, thyroid hormones, and growth hormone. Oestrogen promotes collagen synthesis, maintains skin thickness and hydration, and supports wound healing. Testosterone stimulates sebaceous gland activity. The hormonal changes of perimenopause and menopause (declining oestrogen) cause accelerated collagen loss of up to 30 percent in the first 5 years, reduced skin thickness, decreased sebum production leading to dryness, and impaired wound healing.

What Are Bioidentical Hormones?

Bioidentical hormones are compounds that are chemically identical to the hormones produced by the human body, as opposed to synthetic hormones which have modified molecular structures. They are typically derived from plant precursors (soy, yam) and include 17-beta estradiol, micronised progesterone, testosterone, and DHEA. Available as creams, patches, troches, pellets, and oral preparations.

Evidence for Skin Benefits

Oestrogen and Collagen

Multiple studies demonstrate that systemic oestrogen replacement increases skin collagen content by 5-10 percent annually, increases skin thickness by 7-15 percent, improves skin hydration and elasticity, reduces TEWL, and may slow wound ageing. A landmark study found that women who had taken HRT for 5 or more years had significantly thicker, more hydrated skin than age-matched controls.

Topical Oestrogen

Topical oestradiol (0.01-0.05 percent) applied to facial skin has shown improvements in collagen content, skin thickness, and elasticity in several small studies, potentially without significant systemic absorption. However, regulatory status and safety data for cosmetic use of topical oestrogen remain limited, and this application is not widely approved.

Testosterone and DHEA

Low-dose testosterone may improve skin thickness, collagen density, and sebaceous gland function in women with androgen deficiency. DHEA, a precursor hormone, has shown promise in improving skin ageing parameters in postmenopausal women in preliminary studies.

Risks and Considerations

Bioidentical hormone therapy is not without risks. Oestrogen therapy carries risks of venous thromboembolism, cardiovascular events, and breast cancer that must be weighed against benefits. The Women’s Health Initiative findings, while primarily relevant to synthetic hormones, highlighted the importance of individualised risk assessment. Bioidentical proponents argue that body-identical formulations carry lower risks, but large-scale comparative studies are still needed.

Integrating Hormonal and Aesthetic Approaches

For perimenopausal and menopausal patients experiencing accelerated skin ageing, a combined approach addressing both hormonal and structural factors produces optimal results: hormone optimisation through consultation with an endocrinologist or menopause specialist, alongside aesthetic treatments (collagen stimulation, skin tightening, appropriate injectables) to address existing changes. This integrated approach acknowledges that skin ageing is multifactorial.

Frequently Asked Questions